Aardvark Therapeutics logo

Aardvark Therapeutics

AARD | NASDAQ
Chart Builder DCF Calculator
$1.26
-$0.07 (-5.26%)
At close: Nov 16, 2026, 4:00 PM ET
$1.21
-$0.05 (-4.22%)
After-hours: Nov 16, 2026, 7:30 PM ET
-5.26%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
23
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #964/1021 (Top 94%)

Key Statistics

Market Data

Market Cap $27.57M
1D Range
1.21 1.48
52W Range
1.08 15.82

Valuation (TTM)

PE -0.38
PB 0.48
EV/EBITDA 0.44

Valuation (NTM)

Forward PE N/A
Forward PEG -0.04
Price Target $2.50
Loading financial charts...

Profile

Aardvark Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, concentrating on developing small-molecule treatments. These therapies are designed to stimulate the body's n...

Sector Healthcare
Industry Biotechnology
Employees 28
IPO Date Feb 13, 2025
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
8
Consensus
Hold
Price Target
$2.00
Upside
+58.73%
Buy (3)
Hold (4)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.